MDSO stock: buy or sell?
October 28th, 2019
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development.
Should I buy MDSO stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to define your own trading strategy that fits your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Medidata Solutions stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Medidata Solutions stock a buy?
Banks and financial institutions post stock ratings everyday.At Stocks2.com, we gathered 7 ratings published for MDSO stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-6-12||William Blair||Outperform||Market Perform|
|2019-6-12||Piper Jaffray Companies||Overweight||Neutral|
|2019-6-12||JPMorgan Chase & Co.||Underweight||Neutral|
|2019-4-23||Wells Fargo & Co||Outperform||Market Perform|
MDSO stock analysis
Shares of Medidata Solutions closed on October at $92.22 and stayed stable a neutral -0.02%.
Medidata Solutions shares stayed steady -0.02% to $92.22 on October. Since price and SMA50d lines crossed up on October, MDSO climbed $0.70 (0.76%).
Shares of Medidata Solutions ended this week at $92.22 and stayed stable a neutral -0.02%.
Since early May when SMA20w and SMA40w crossed up, MDSO price slipped $-1.75 per share (-1.86%). Since early April when MDSO stock price broke up the SMA40w line, it gained $18.98 (25.91%). Far behind is the all-time high Medidata Solutions hit late April but price is just -6.47% below that top.
MDSO stock price history
MDSO IPO was on June 25th, 2009 at $9.00 per share1. Since then, MDSO stock surged a 924.70%, with a yearly average of 92.50%. If you had invested right after MDSO's IPO a $1,000 in MDSO stock in 2009, it would worth $9,247.00 today.
1: Adjusted price after possible price splits or reverse-splits.
MDSO stock historical price chart
MDSO stock reached all-time highs on April with a price of $98.60.
MDSO stock price target is $92.30Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. Currently, only 1 price prediction for Medidata Solutions stock was posted in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-6-13||SunTrust Banks||Raises Target||$85.00||$92.25||8.5%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Medidata Solutions reported its latest financial data, posting an outstanding gain for the Earnings per Share (EPS). Analyst expected $0.16 per share, but Medidata Solutions posted $0.26.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Medidata Solutions annual sales skyrocketed a dazzling 16.81% to $635.70 M USD from $544.21 marked in 2017. Nevertheless, its earnings margin (compared to sales) remained stable to 8.17%, that is $51.92 million.
|2013||$277 M||-||$17 M6.0%||-|
|2014||$335 M||21.03%||$6.09 M1.8%||-63.43%|
|2015||$393 M||17.14%||$13 M3.4%||116.14%|
|2016||$463 M||18.06%||$29 M6.3%||120.12%|
|2017||$544 M||17.44%||$48 M8.7%||64.15%|
|2018||$636 M||16.81%||$52 M8.2%||9.13%|
Quarterly financial resultsMedidata Solutions posted $167.19 million in revenues for 2018-Q4, a 2.31% improvement compared to previous quarter. Reported quarter income marked $14.32 million with a profit margin of 8.56%. Profit margin grew a 2.02% compared to previous quarter when profit margin was 6.54%. When comparing turnover to same quarter last year, Medidata Solutions sales marked an astounding growth and climbed a 16.98%. Looking back to recent quarterly results, Medidata Solutions posted 6 positive quarters in a row.
|2017-Q2||$137 M||-||$8 M6.0%||-|
|2017-Q3||$140 M||1.94%||$13 M9.2%||55.64%|
|2017-Q4||$143 M||2.02%||$14 M9.7%||7.60%|
|2018-Q1||$149 M||4.40%||$10 M6.9%||-25.27%|
|2018-Q2||$156 M||4.50%||$17 M10.6%||60.67%|
|2018-Q3||$163 M||4.81%||$11 M6.5%||-35.57%|
|2018-Q4||$167 M||2.31%||$14 M8.6%||33.97%|
|2019-Q1||$174 M||3.78%||$11 M6.4%||-22.17%|
Medidata Solutions ownershipWhen you are planning to buy a company, it's worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medidata Solutions, of all outstanding shares are owned by its staff.
For a better understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$0.0 M|
|Total shares||0.0 M|
|Float shares||0.0 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Monday, October 28th, 2019|
|Day range||$92.21 - $92.26|
|Average true range||$0.17|
|50d mov avg||$91.72|
|100d mov avg||$91.43|
|200d mov avg||$85.43|
Medidata Solutions performanceTo measure stock performance is always good to compare with competitors or related stocks. For Medidata Solutions, the benchmark is made against .